MDGL MADRIGAL PHARMACEUTICALS, INC.

NEUTRAL Impact: 4/10 Insider Cluster (7 insiders)
Horizon days Filed Mar 2, 2026 Processed 3mo ago
Insider cluster: 5 insiders, $1.8M total
Final — all horizons settled through T+60d ⚠ clustered
MDGL ▲ +20.35% at T+60d
NEUTRAL call ✓ call won +20.35% · α vs SPY +11.03% · entry $435.62 → $524.28
Currently $476.89 · +9.47% from $435.62 entry
Entry anchored
Feb 27, 03:59 PM ET
via Databento tick
T+1d
-2.24%
call -2.24% · α -1.33%
$425.85
settled 3mo ago
T+5d
-0.56%
call -0.56% · α +0.65%
$433.20
settled 3mo ago
T+20d
+16.00%
call +16.00% · α +23.94%
$505.34
settled 3mo ago
T+60d
+20.35%
call +20.35% · α +11.03%
$524.28
settled 15d ago

Price Chart

Loading chart...

Executive Summary

Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and other C-suite executives, conducted open-market sales and stock awards within a 7-day window. The total value of open-market sales was approximately $2.37 million, representing modest insider selling activity at a company with a $10.1 billion market cap.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
7

Actionable Insight

Monitor for continued insider selling in the next 30 days; isolated transactions at this level are routine, but a pattern could signal reduced confidence. The non-cash grants are standard compensation and not actionable.

Key Facts

  • CEO William Sibold sold $718,316 worth of shares in open-market transactions on March 6, 2026.
  • CFO Mardi Dier sold $505,389 worth of shares on March 2, 2026.
  • Four other C-suite executives sold shares totaling $1.15 million on March 6.
  • Five insiders received non-cash stock awards totaling 27,375 shares on March 4, 2026.
  • Total open-market selling amounted to $2.37 million over 7 days.
  • Selling represents ~0.023% of the company's $10.1 billion market capitalization.

Financial Impact

$2.37 million in open-market insider sales over 7 days, representing 0.023% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Perception of insider profit-taking following a potential price run-up
  • Risk of negative sentiment if selling continues in coming weeks

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (9 trades, 7d window)cluster-MDGL-1772840985473
7 reports for MDGL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MDGL — sortable, filterable
Type Now
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$524.28 $452.86▼ −13.62%▼ −14.84%$476.89 (−9.04%)
May 6, 2026
4w ago
8-K
BULLISH ★ 7/10
$539.73 $510.26▼ −5.46%▼ −6.59%$476.89 (−11.64%)
Apr 28, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$518.58 $539.73▲ +4.08%▲ +0.97%$476.89 (−8.04%)
Apr 22, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$529.14 $511.85▼ −3.27%▼ −3.32%$476.89 (−9.87%)
Mar 19, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$441.16 $510.68▲ +15.76%▲ +17.91%$476.89 (+8.10%)
Mar 2, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$435.62 $433.20▼ −0.56%▲ +0.65%$476.89 (+9.47%)
Mar 2, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$435.62 $433.20▼ −0.56%▲ +0.65%$476.89 (+9.47%)
Showing 7 of 7

US Market Status

Market Closed — Opens Thu (10h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access